How should a 5 mg dose of metoprolol be administered, including route, infusion rate, contraindications, and monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Metoprolol 5 mg IV Administration Protocol

Administer metoprolol 5 mg as an intravenous bolus over approximately 2 minutes, repeated every 5 minutes for up to 3 doses (total 15 mg maximum) if tolerated, with continuous monitoring of blood pressure, heart rate, and ECG during administration 1, 2.

Route and Infusion Rate

  • Route: Intravenous bolus injection
  • Dose: 5 mg per bolus
  • Rate: Administer over approximately 2 minutes 2
  • Frequency: May repeat every 5 minutes as tolerated 1
  • Maximum: Up to 3 doses (15 mg total) 1, 2

Clinical Context and Indications

The 5 mg IV dose is specifically indicated for:

  • Acute myocardial infarction (early treatment phase) 1, 2
  • Refractory hypertension in STEMI patients 1
  • Ongoing ischemia without contraindications 1

Absolute Contraindications - DO NOT GIVE IF:

  • Signs of heart failure (rales, S3 gallop, jugular venous distension)
  • Low output state (cool extremities, altered mental status, oliguria)
  • Increased risk for cardiogenic shock, particularly:
    • Age >70 years
    • Systolic BP <120 mm Hg
    • Heart rate >110 bpm or <60 bpm
    • Prolonged time since symptom onset 1
  • High-grade AV block: PR interval >0.24 seconds, second- or third-degree heart block 1
  • Active asthma or reactive airways disease 1
  • Systolic BP <90 mm Hg or >30 mm Hg below baseline 1

Required Monitoring

Must be administered in an intensive monitoring setting 2:

  • Continuous ECG monitoring
  • Blood pressure measurement before each dose
  • Heart rate assessment before each dose
  • Clinical assessment for signs of heart failure or cardiogenic shock

Titrate to heart rate and blood pressure response - hold subsequent doses if:

  • Systolic BP drops below 90 mm Hg
  • Heart rate falls below 50-60 bpm
  • Development of AV block
  • Signs of heart failure emerge

Transition to Oral Therapy

If patient tolerates full IV dose (15 mg total):

  • Start metoprolol tartrate 50 mg orally every 6 hours
  • Begin 15 minutes after the last IV dose
  • Continue for 48 hours
  • Then transition to 100 mg twice daily for maintenance 1, 2

If patient shows intolerance to full IV dose:

  • Start 25-50 mg orally every 6 hours (depending on degree of intolerance)
  • Begin 15 minutes after last IV dose or when clinically stable 2

Critical Pitfalls to Avoid

The COMMIT/CCS-2 trial demonstrated that early IV metoprolol followed by high-dose oral therapy showed increased cardiogenic shock rates, especially on days 0 and 1, particularly in elderly patients and those with hemodynamic compromise 1. This underscores the importance of strict adherence to contraindication screening.

Do not administer to patients with multiple risk factors for cardiogenic shock - the greater the number of risk factors present (age >70, SBP <120, HR >110 or <60, delayed presentation), the higher the risk 1.

Special Populations

  • Elderly (>65 years): Use cautiously; higher risk of cardiogenic shock and adverse effects 1, 2
  • Hepatic impairment: Blood levels increase substantially; if IV metoprolol is necessary, use with extreme caution and consider lower doses 2
  • Renal impairment: No dose adjustment required 2

Storage and Preparation

  • Store at 20-25°C (68-77°F)
  • Protect from light; retain in carton until use
  • Do not freeze
  • Inspect visually for particulate matter before administration 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.